Altre lingue Elanco Animal Health Incorporated

Azioni

ELAN

US28414H1032

Prodotti farmaceutici

Mercato chiuso - Nyse Altri mercati azionari 22:00:02 17/06/2025			Variaz. 5gg	Var. 1 gen.
13,61 ^USD	-2,72%		-2,23%	+12,39%

12/06	Elanco ottiene un "parere positivo" dall'Agenzia europea per i medicinali per un farmaco contro il prurito canino	MT
12/06	Elanco riceve parere positivo su Zenrelia dal Comitato dell'UE	RE

Altre lingue

Elanco Gets 'Positive Opinion' on Canine Itch Drug From European Medicines Agency	12/06
Elanco Receives Positive Opinion On Zenrelia From EU's Committee	12/06
Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products (CVMP)	12/06
Elanco Receives Positive Opinion on Zenrelia (ilunocitinib) from EU's Committee for Veterinary Medicinal Products	12/06
Elanco Releases New Report Highlighting the Significance of America's Itchy Dogs and the Need for Itch Relief	06/06
Elanco Animal Health Incorporated Releases New Report Highlighting the Significance of America's Its Dogs and the Need for Itch Relief	05/06
How Elanco Plans on Winning in the Pet Wellness Boom	28/05
Elanco Animal Health Incorporated Announces CFO Changes	28/05
Elanco Animal Health Incorporated Announces Change of Executive Vice President	28/05
Elanco Animal Health Incorporated Reconfirms Earnings Guidance for the Second Quarter and Full Year 2025	28/05
Elanco Animal Health Names Robert VanHimbergen CFO	28/05
Elanco Appoints Robert Vanhimbergen As Chief Financial Officer	28/05
Elanco to Participate in the Upcoming Investor Conferences	16/05
Sector Update: Health Care Stocks Rise Late Afternoon	07/05
Elanco Animal Health Shares Rise After Q1 Beat	07/05
Elanco Animal Health's Q1 Adjusted Earnings Rise, Revenue Falls; Raises 2025 Revenue Guidance	07/05
Elanco Animal Health Incorporated : Investor Overview	07/05
Elanco Animal Health Incorporated : First Quarter 2025 Earnings Presentation	07/05
Elanco Animal Health Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2025	07/05
Earnings Flash (ELAN) Elanco Animal Health Reports Q1 Revenue $1.19B, vs. FactSet Est of $1.17B	07/05
Earnings Flash (ELAN) Elanco Animal Health Posts Q1 Adjusted EPS $0.37, vs. FactSet Est of $0.31	07/05
Elanco Animal Health Incorporated Updates Earnings Guidance for the Full Year 2025	07/05
Elanco Animal Health Incorporated Provides Earnings Guidance for the Second Quarter of 2025	07/05
Elanco Sells Xdemvy Royalty, Milestone Rights to Blackstone Affiliates for $295 Million	05/05
Elanco Sells Royalty And Milestone Rights For Lotilaner In Human Health To Blackstone Accelerates Debt Paydown	05/05

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Trascrizioni Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Ultime notizie

Come Elanco intende affermarsi nel boom del benessere degli animali domestici

28 maggio 2025 alle 18:13